EMA — authorised 31 March 2021
- Marketing authorisation holder: Novo Nordisk A/S
- Status: approved
🇪🇺 Sogroya in European Union
EMA authorised Sogroya on 31 March 2021
Marketing authorisation
Sogroya in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Sogroya approved in European Union?
Yes. EMA authorised it on 31 March 2021.
Who is the marketing authorisation holder for Sogroya in European Union?
Novo Nordisk A/S holds the EU marketing authorisation.